Global Cancer Biologics Market 2019-2023 – Increased Use of Predictive Biomarkers | Technavio

07:00 EDT 31 Oct 2019 | Businesswire
This article has expired, however you can still download the PDF.
Accelerated approvals of new biologics will drive market growth in North America Technavio’s report on the cancer biologics market is expected to grow by $40.38 billion during 2019-2023. The increasing investments in the development of cancer biologics...

Other Sources for this Article

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200


More From BioPortfolio on "Global Cancer Biologics Market 2019-2023 – Increased Use of Predictive Biomarkers | Technavio"

Quick Search

Relevant Topics

The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...